Tweets by SSO 2024 Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Recorded for On-Demand Viewing

Type here to filter the list

Thursday, Mar 21st
9:30am – 10:30am ET
The Evolution of Sequence of Treatment and Axillary Management in Early-stage Breast Cancer
Location: Georgia Ballroom
Moderator: Laura Dominici, MD – Brigham and Women's Faulkner Hospital; Associate Surgeon, Brigham and Women's Hospital, Dana-Farber Cancer Institute
Moderator: Astrid Botty van den Bruele, MD – Duke University Medical Center
BreastCME
Thursday, Mar 21st
11:20am – 12:05pm ET
Breast Great Debates in Surgical Oncology - Does Breast-conserving Surgery with Radiotherapy offer Better Survival than Mastectomy in Early-stage Breast Cancer?
Location: C101
Moderator: Kandace P. McGuire, MD – Virginia Commonwealth University Health
BreastCME
Thursday, Mar 21st
12:15pm – 12:35pm ET
Industry Spotlight Presented by Pacira: Getting to NOPAIN: Enhancing outcomes with advanced pain management techniques to allow for migration to the hospital outpatient setting
Location: SSO HUB Theater
HUB Presenter: Uma L. Shastri, MD, FRCPC – Northside Anesthesiology Consultants
Breastnon-CMEHUB
Thursday, Mar 21st
2:00pm – 2:30pm ET
Breast Cancer in Special Populations: Pregnancy Associated Breast Cancer and Male Breast Cancer
Location: SSO HUB: Breast & Endocrine Zone
HUB Moderator: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Breastnon-CMEHUB
Thursday, Mar 21st
2:40pm – 3:00pm ET
Industry Spotlight Presented by Elucent: EnVision: Tailored Precision for Every Patient, Every Time.
Location: SSO HUB Theater
HUB Presenter: Lee G. Wilke, MD (she/her/hers) – University of Wisconsin, School of Medicine and Public Health, Madison, WI
Breastnon-CMEHUB
Thursday, Mar 21st
3:45pm – 4:15pm ET
Breast Poster Presentations 1
Location: C110
Poster Session Moderator: Laura H. Rosenberger, MD MS (she/her/hers) – Duke University
Poster Session Moderator: Makesha V. Miggins, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
Breastnon-CMEPosters
Thursday, Mar 21st
3:45pm – 3:51pm ET
P1: High spermidine expression is associated with high cell proliferation and worse survival but respond better to immunotherapy in ER-positive/HER2-negative breast cancer.
Location: C110
Oral Poster Presenter: Faisal S. Jehan, MD, FICS – Roswell Park Comprehensive Cancer Center.
Submitter: Faisal S. Jehan, MD, FICS – Roswell Park Comprehensive Cancer Center.
Author: Masanori Oshi, MD – Roswell Park Comprehensive Cancer Center
Author: Itaru Endo, MD PhD – University of Yokohama
Author: Kazuaki Takabe, MD, PhD – Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center
Breast
Thursday, Mar 21st
3:51pm – 3:57pm ET
P2: Impact of Race and Ethnicity on Recurrence Risk in Patients with Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery
Location: C110
Oral Poster Presenter: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: V. Morgan Jones, MD – Memorial Sloan Kettering Cancer Center
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
Author: Kimberly J. Van Zee, MS, MD – Memorial Sloan Kettering Cancer Center
Author: Andrea V. Barrio, MD – Memorial Sloan Kettering Cancer Center
Breast
Thursday, Mar 21st
3:57pm – 4:03pm ET
P3: Patient Satisfaction Following Pilot of Decision Aid to Reduce Overtreatment of Older Women with Early-Stage Breast Cancer
Location: C110
Oral Poster Presenter: Ruby Kazemi, BA – University of Michigan Medical School
Submitter: Ruby Kazemi, BA – University of Michigan Medical School
Author: Ruby Kazemi, BA – University of Michigan Medical School
Author: Cecilia Pesavento, MD, MBA – Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN
Author: Abigail Kappelman, MA, BA – University of Michigan Medical School, Ann Arbor, MI
Author: Chad Jobin, MSW – Michigan Medicine, Ann Arbor, MI
Author: Jessica Thompson, MD – Corewell Health West, Department of Cancer Health, Grand Rapids, MI
Author: Ton Wang, MD, MS – Duke University
Author: Lesly A. Dossett, MD, MPH (she/her/hers) – University of Michigan
Breast
Thursday, Mar 21st
4:03pm – 4:09pm ET
P4: Breast conserving therapy is a safe option for women under 40 diagnosed with breast cancer
Location: C110
Oral Poster Presenter: Arith Ruth S. Reyes, MD – Columbia University Medical Center
Submitter: Arith Ruth S. Reyes, MD – Columbia University Medical Center
Author: Arith Ruth S. Reyes, MD – Columbia University Medical Center
Author: Eunice Y. Lee, MD PhD – University of California, San Francisco
Author: Courtney Connelly, MD – Columbia University Medical Center
Author: Jonathan Wyrick, MD – Rutgers New Jersey Medical School
Author: Roshni Rao, MD – Columbia University Medical Center
Author: Luona Sun, MD – Columbia University Medical Center
Author: Bret Taback, MD – Columbia University Medical Center
Author: Stacy K. Ugras, MD – Columbia University Medical Center
Author: Lisa S. Wiechmann, MD – Columbia University Medical Center
Breast
Thursday, Mar 21st
7:00pm – 8:30pm ET
PeerView Early Breast Cancer Symposium
Location: C108
Chair: Laura Dominici, MD – Brigham and Women's Faulkner Hospital; Associate Surgeon, Brigham and Women's Hospital, Dana-Farber Cancer Institute
Presenter: Albert Henry Diehl, III, MD, FACS – Atlanta Breast Care
Presenter: Jane L. Meisel, MD – Winship Cancer Institute, Emory University School of Medicine
BreastCME
Friday, Mar 22nd
10:30am – 12:00pm ET
Breast Parallel Session 1
Location: Georgia Ballroom
Moderator: Meeghan A. Lautner, MD, MSc, FACS (she/her/hers) – University of Wisconsin Department of Surgery
Moderator: Kathie Ann Joseph, MD, MPH (she/her/hers) – NYU
BreastCMEOral Abstracts
Friday, Mar 22nd
10:32am – 10:42am ET
11: A Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits TNBC Lung Metastases
Location: Georgia Ballroom
Abstract Presenter: Lillian Hsu, MD (she/her/hers) – MUSC
Submitter: Lillian Hsu, MD (she/her/hers) – MUSC
Author: Lillian Hsu, MD (she/her/hers) – MUSC
Author: Patrick Nasarre, PhD – MUSC
Author: Julie B. Siegel, MD (she/her/hers) – MUSC
Author: Eleanor Hilliard, BS – MUSC
Author: Rupak Mukherjee, PhD – MUSC
Author: Nancy Klauber DeMore, MD – MUSC
Breast
Friday, Mar 22nd
10:42am – 10:52am ET
9: The Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Location: Georgia Ballroom
Abstract Presenter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
Submitter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
Author: Tanya L. Hoskin, MS – Mayo Clinic
Author: Roberto A. Leon Ferre, MD – Mayo Clinic
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Breast
Friday, Mar 22nd
10:52am – 11:02am ET
8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results
Location: Georgia Ballroom
Author: Fengjuan Zhang, PhD – University of Pennsylvania
Author: Joseph Fraietta, PhD – Universiy of Pennsylvania
Author: Amy Clark, MD – University of Pennsylvania
Author: Neil taunk, MD – University of Pennsylvania
Author: Nucleus H Xu, PhD – University of Pennsylvania
Author: Anupma Nayak, MD – University of Pennsylvania
Author: Zahra Ahmad, BS – University of Pennsylvania
Author: Diego Gonzalves, BA – University of Pennsylvania
Author: Alexander C Huang, MD – University of Pennsylvania
Author: Andy Minn, MD PhD – University of Pennsylvania
Abstract Presenter: Julia Tchou, MD PhD – University of Pennsylvania
Submitter: Julia Tchou, MD PhD – University of Pennsylvania
Breast
Friday, Mar 22nd
11:02am – 11:12am ET
5: Change in Biomarker Profile after neoadjuvant chemotherapy is especially common in patients with HER2+ breast cancer subtype
Location: Georgia Ballroom
Abstract Presenter: Soumy Gottipati, BS (she/her/hers) – UCSF
Author: Soumy Gottipati, BS (she/her/hers) – UCSF
Author: molly Baxter, BA – UCSF
Author: Yunn-yi Chen, MD PhD – UCSF
Author: Sara J Venters, PhD – UCSF
Author: Macy Goldbach, BS – University of Pennsylvania
Author: Diego Gonzalves, BA – University of Pennsylvania
Author: Anupma Nayak, MD – University of Pennsylvania
Author: Rita A. Mukhtar, MD – University of California, San Francisco
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Author: Julia Tchou, MD PhD – University of Pennsylvania
Breast
Friday, Mar 22nd
11:12am – 11:22am ET
10: Potential Overtreatment of DCIS in Patients with Limited Life Expectancy
Location: Georgia Ballroom
Abstract Presenter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Submitter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Author: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Author: Yu-Jen Chen, MPH – Center for Surgery and Public Health, Brigham and Women's Hospital
Author: Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Author: Elizabeth A. Mittendorf, MD, PhD, MHCM (she/her/hers) – Brigham and Women's Hospital, Dana Farber Cancer Institute
Author: Christina A. Minami, MD, MS (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Breast
Friday, Mar 22nd
11:22am – 11:32am ET
6: Impact of clipped node as a sentinel lymph node on axillary staging following neoadjuvant chemotherapy in clinically node-positive breast cancer
Location: Georgia Ballroom
Abstract Presenter: Alexandra Moore, MD – MD Anderson Cancer Center
Submitter: Alexandra Moore, MD – MD Anderson Cancer Center
Author: Alexandra Moore, MD – MD Anderson Cancer Center
Author: Abigail S. Caudle, MD, MS, FACS – MD Anderson Cancer Center
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Author: Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Savitri Krishnamurthy, MD – MD Anderson Cancer Center
Author: Wei Yang, MBBS, FRCR – MD Anderson Cancer Center
Author: Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Vicente Valero, MD, FACP – MD Anderson Cancer Center
Author: Mediget Teshome, MD (she/her/hers) – UCLA
Breast
Friday, Mar 22nd
11:32am – 11:42am ET
4: International Validation of a Staging Model for de novo Metastatic Breast Cancer
Location: Georgia Ballroom
Abstract Presenter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Submitter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Author: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Author: Samantha M. Thomas, MS – Duke Cancer Institute
Author: Sabine Siesling, PhD – Department of Research and Development, Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands; Department of Health Technology andServices Research, University of Twente, Technical Medical Centre, Enschede, TheNetherlands
Author: Linda De Munck, MSc – Department of Research and Development; Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands
Author: Amélie Lusque, MS – Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT-oncopole,Toulouse, France
Author: Thomas Grinda, MD, MSc – Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800Villejuif, France
Author: Lovedeep Gondara, PhD, MS – BCCancer –Data and Analytics
Author: Stephen Chia, MD, FRCP – Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
Author: Paula Cabrera-Galeana, MD, MSc – Breast Medical Oncology Department, Instituto Nacional de Cancerología
Author: Nancy Reynoso-Noverón, MD, MS – Instituto Nacional de Cancerología, CDMX, México
Author: Sara López-Tarruella Cobo, MD, PhD – Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria GregorioMarañón (IiSGM), Universidad Complutense. CIBERONC-ISCIII. GEICAM Spanish BreastCancer Group. Madris, Spain
Author: Isabel Alvarez Lopez, MD – Medical Oncology Unit of Donostia University Hospital (Donostialdea IHO); GEICAM,Madrid, Spain
Author: Stephen B. Edge, MD (he/him/his) – Department of Surgical Oncology and Cancer Prevention and Control, University atBuffalo. Buffalo, NY, USA; Roswell Park Comprehensive Cancer Center. Buffalo, NY, USA
Author: Gabriel Hortobagyi, MD – Department of Breast Medical Oncology, Division of Cancer Medicine, The University ofTexas MD Anderson Cancer Center, Houston, TX, USA
Breast
Friday, Mar 22nd
11:42am – 11:52am ET
7: Routine Use of Cavity Shave Margins with Breast Conserving Surgery Lowers Re-Excision Rates in a High Volume, Large Group Practice
Location: Georgia Ballroom
Abstract Presenter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Submitter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Author: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Author: Annie Tang, MD – University of California San Francisco
Author: Gillian Kuehner, MD – The Permanente Medical Group
Author: Alison Savitz, MD – The Permanente Medical Group
Author: Maris Jones, MD – The Permanente Medical Group
Author: Lakhbir Sandhu, MD – The Permanente Medical Group
Author: Mindy Young-Reeves, MD – The Permanente Medical Group
Author: Maihgan Kavanagh, MD – The Permanente Medical Group
Author: Sharon Chang, MD – The Permanente Medical Group
Breast
Friday, Mar 22nd
12:15pm – 12:45pm ET
Expert Perspectives: Assessing Residual Tumor Burden After Neoadjuvant Therapy for Breast Cancer
Location: SSO HUB: Breast & Endocrine Zone
HUB Presenter: Aysegul Sahin, MD
HUB Moderator: Amanda M. Woodworth, MD, FACS, FSSO, CPE (she/her/hers) – Keck Medicine of USC
Breastnon-CMEHUB
Friday, Mar 22nd
1:02pm – 1:14pm ET
1: Are Nodal ITCs After Neoadjuvant Chemotherapy An Indication For Axillary Dissection? The OPBC-05/EUBREAST-14R/ICARO study
Location: Georgia Ballroom
Abstract Presenter: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Submitter: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Author: Alison Laws, MD, MPH – Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
Author: Jessica M. Pastoriza, MD – Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
Author: Marie-Jeanne Vrancken Peeters, MD, PhD – Stichting HET Netherlands Kanker Instituut-Antoni van Leeuwenhoek, Amsterdam, Netherlands
Author: Massimo Ferrucci, MD, PhD – Padua Italy
Author: Mary M. Mrdutt, MD, MS – Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA
Author: Güldeniz Karadeniz Cakmak, MD, FEBS – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey
Author: Hakan Balbaloglu, MD – Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey
Author: Nuran Bese, MD – Research Institute of Senology Acibadem, Istanbul, Turkey
Author: Neslihan Cabioğlu, MD – Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Author: Claire M. M. Eden, MD – New York Presbyterian, Weill Cornell Medicine, New York, NY, USA
Author: Callie Hlavin, MD, MPH – University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Author: Susan B. B. Kesmodel, MD, FACS – Department of Surgery, Division of Surgical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA
Author: Tehillah S. Menes, MD – Sheba Medical Center, Tel Hashomer, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Author: Ekaterini Christina Tampaki, MD, PhD – KAT Athens General Hospital, Department of Plastic, Reconstructive Surgery & Burn Unit, Athens, Greece; National Organization for the Provision of Healthcare Services, Hellenic National Contact Point, Department of Planning and Monitoring of Medicines Dispensing, Medicines Division, Athens, Greece
Author: Stephanie M. M. Wong, MD, MPH – Department of Surgery, McGill University Medical School, Montreal, QC, Canada; Sir Mortimer B. Davis Jewish General Hospital, QC, Montreal, Canada
Author: Jennifer Q. Q. Zhang, MD – Division of Breast Surgery, Department of Surgery, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
Author: Walter P. P. Weber, MD (he/him/his) – Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland
Breast
Friday, Mar 22nd
1:14pm – 1:26pm ET
2: Phase 3 study of neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer: KEYNOTE-756
Location: Georgia Ballroom
Author: Fatima Cardoso, n/a – Champalimaud Foundation, Lisbon, Portugal
Author: Joyce O’ Shaughnessy, MD – Baylor University Medical CenterTexas Oncology, US Oncology Network, Dallas, TX, USA
Abstract Presenter: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
Submitter: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
Author: Heather McArthur, MD MPH (she/her/hers) – Dallas, TX, USA
Author: Peter Schmid, n/a – Barts Cancer Institute, Queen Mary University London, London, UK
Author: Javier Cortes, n/a – Quironsalud Group, Barcelona, Spain and Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain
Author: Nadia Harbeck, n/a – LMU University Hospital, Munich, Germany
Author: Melinda L. Telli, n/a – Stanford, CA, USA
Author: David W. Cescon, n/a – Toronto, Ontario, Canada
Author: Peter A. Fasching, n/a – Comprehensive Cancer Center Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Erlangen, Germany
Author: Zhimin Shao, n/a – Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Author: Delphine Loirat, n/a – Paris, France
Author: Yeon Hee Park, n/a – Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Author: Manuel Gonzalez Fernandez, n/a – IMAT-Oncomedica, Montería, Colombia
Author: Gábor Rubovszky, n/a – Budapest, Hungary
Author: Seock-Ah Im, n/a – Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Author: Rina Hui, n/a – Westmead Hospital and the University of Sydney, Sydney, NSW, Australia; Centre of Cancer Medicine, the University of Hong Kong, Hong Kong
Author: Toshimi Takano, n/a – Tokyo, Japan
Author: Fabrice André, n/a – Gustave Roussy, Villejuif, France
Author: Hiroyuki Yasojima, n/a – NHO Osaka National Hospital, Osaka, Japan
Author: Zhenzhen Liu, n/a – Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China
Breast
Friday, Mar 22nd
1:26pm – 1:38pm ET
3: Oncologic Outcomes with De-Escalation of Axillary Surgery after Neoadjuvant Chemotherapy for Breast Cancer: Results from >1,500 patients on the I-SPY2 Clinical Trial
Location: Georgia Ballroom
Abstract Presenter: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Submitter: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Author: Hongmei Yu, Ph.D. – Quantum Leap Healthcare Collaborative
Author: Kayla Switalla, B.S. – University of California, San Francisco
Author: Ladores Velle, B.S. – University of California, San Francisco
Author: Anne M. Wallace, M.D. – UC San Diego Health
Author: Rachel B. Lancaster, M.D. – The University of Alabama at Birmingham Medical Center
Author: Chantal R. Reyna, M.D. – Loyola University Medical Center
Author: Todd M. Tuttle, MD MS – Division of Surgical Oncology, Department of Surgery, University of Minnesota
Author: Nora Jaskowiak, M.D. – The University of Chicago Medicine
Author: Julia Tchou, MD PhD – University of Pennsylvania
Author: Roshni Rao, MD – Columbia University Medical Center
Author: Marie Catherine Lee, MD, FACS – Moffitt Cancer Center
Author: Arpana M. Naik, M.D. – Oregon Health & Science University
Author: Mehra Golshan, MD, MBA, FACS – Yale School of Medicine Department of Surgery
Author: Cletus A. Arciero, M.D. – Emory University School of Medicine
Author: Candice A. Sauder, M.D. – UC Davis Comprehensive Cancer Center
Author: Cindy B. Matsen, M.D. – University of Utah Health
Author: Laura Essermann, M.D., M.B.A – University of California, San Francisco
Author: Rita A. Mukhtar, MD – University of California, San Francisco
Author: ISPY2 Locoregional Working Group, . – UCSF
Breast
Friday, Mar 22nd
3:45pm – 4:15pm ET
Contralateral Breast Cancer (CBC) and Contralateral Prophylactic Mastectomy (CPM)
Location: SSO HUB: Breast & Endocrine Zone
HUB Moderator: Christine Laronga, MD (she/her/hers) – Lee Moffitt
Breastnon-CMEHUB
Saturday, Mar 23rd
8:00am – 9:30am ET
Breast Parallel Session 2
Location: C101
Moderator: Richard J. Bleicher, MD – Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
Moderator: Marissa M. Howard-McNatt, MD – Wake Forest Baptist Health
BreastCMEOral Abstracts
Saturday, Mar 23rd
8:00am – 8:10am ET
12: Clinical outcomes in BRCA mutation carriers treated with breast conserving therapy
Location: C101
Abstract Presenter: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Submitter: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Kerollos N. Wanis, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Author: Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Alexa C. Glencer, MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Mediget Teshome, MD (she/her/hers) – UCLA
Author: Anthony Lucci, Jr., MD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Roi Weiser, MD – Department of Surgical Oncology, MD Anderson Cancer Center
Author: Helen M. Johnson, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Angelica M. Gutierrez, MS – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Simona F. Shaitelman, MD, EdM – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Banu K. Arun, MD – Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Breast
Saturday, Mar 23rd
8:10am – 8:20am ET
13: Predictors of Nodal Clearance After Neoadjuvant Chemotherapy in Breast Cancer
Location: C101
Abstract Presenter: Selena J. An, MD, MSPH, MA – University of North Carolina
Submitter: Selena J. An, MD, MSPH, MA – University of North Carolina
Author: Selena J. An, MD, MSPH, MA – University of North Carolina
Author: Christine Hong Ngoc Che Thai, BS – University of North Carolina
Author: Conner Haase, MD – University of North Carolina
Author: Julia M. Selfridge, MD – University of North Carolina
Author: Chris Agala, PhD – UNC Hospital
Author: Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine
Author: Philip Spanheimer, MD (he/him/his) – University of North Carolina
Breast
Saturday, Mar 23rd
8:20am – 8:30am ET
14: Three-dimensional navigated mass spectrometry for intraoperative margin assessment during breast cancer surgery
Location: C101
Abstract Presenter: Shaila J. Merchant, MD – Queen's University
Author: Martin Kaufmann, PHD – Queen's University
Author: Amoon Jamzad, PhD – Queen's University
Author: Tamas Ungi, MD, PhD – Queen's University
Author: Jessica Rodgers, PhD – University of Manitoba
Author: Teaghan Koster, MD – Queen's University
Author: Yeung Chris, BSc – Queen's University
Author: Natasja Janssen, PhD – Queen's University
Author: Julie McMullen, MSc – Queen's University
Author: Kathryn Solberg, MSc – Queen's University
Author: Joanna Cheesman, MSc – Queen's University
Author: Kevin Yi Mi Ren, MD – Queen's University
Author: Sonal Varma, MD – Queen's University
Author: Shaila J. Merchant, MD – Queen's University
Author: Cecil Jay Engel, MD – Queen's University
Author: G Ross Walker, MD – Queen's University
Author: Andrea Gallo, MD – Queen's University
Author: Doris Jabs, MD – Queen's University
Author: Parvin Mousavi, PhD – Queen's University
Author: Gabor Fichtinger, PhD – Queen's University
Author: John Rudan, MD – Queen's University
Breast
Saturday, Mar 23rd
8:30am – 8:40am ET
15: Impact of Race on Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy and Chemotherapy Alone for Early-Stage Triple-Negative Breast Cancer
Location: C101
Abstract Presenter: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
Submitter: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: Natalia Polidorio, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: Lauren M. Perry, MD, MAS – Memorial Sloan Kettering Cancer Center
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
Author: Giacomo Montagna, MD, MPH – Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Author: Nour Abuhadra, MD – Memorial Sloan Kettering Cancer Center
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
Author: Stephanie Downs-Canner, MD – Memorial Sloan Kettering Cancer Center
Author: George Plitas, MD – Memorial Sloan Kettering Cancer Center
Breast
Saturday, Mar 23rd
8:40am – 8:50am ET
16: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma in Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)
Location: C101
Abstract Presenter: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Submitter: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Author: Faina Nakhlis, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Author: Gabrielle Baker, MD – Beth Israel Deaconess Medical Center
Author: Tianyu Li, MS – Dana-Farber Cancer Institute
Author: Rebecca Gelman, PhD – Dana-Farber Cancer Institute
Author: George Plitas, MD – Memorial Sloan Kettering Cancer Center
Author: Kandice K. Ludwig, MD – Indiana University
Author: Priscilla McAuliffe, MD – UPMC Hillman Cancer Center
Author: Marc Boisvert, MD – MedStar Washington Hospital Center, Georgetown University
Author: E. Shelley Hwang, MD, MPH – Duke University School of Medicine
Author: Kristalyn K. Gallagher, DO (she/her/hers) – UNC School of Medicine
Author: Lisa Jacobs, MD – Johns Hopkins Medicine
Author: Suniti Nimbkar, MD – South Shore Hospital in clinical affiliation with Dana-Farber Brigham Cancer Center
Author: Sheldon Feldman, MD – Montefiore Medical Center
Author: Paulina Lange, BS – Dana-Farber Cancer Institute
Author: Victoria Attaya, BS – Dana-Farber Cancer Institute
Author: Michelle DeMeo, BS – Dana-Farber Cancer Institute
Author: Ashton Fraettarelli, BA – Dana-Farber Cancer Institute
Author: Stuart Schnitt, MD – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Author: Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Breast
Saturday, Mar 23rd
8:50am – 9:00am ET
17: Omission of Routine Frozen Section Among Clinically Node-Negative Patients Having Upfront Mastectomy Avoids Unnecessary Axillary Treatment
Location: C101
Abstract Presenter: Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Rachel Sargent, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
Author: Andrea V. Barrio, MD – Memorial Sloan Kettering Cancer Center
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
Submitter: Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Breast
Saturday, Mar 23rd
9:00am – 9:10am ET
18: SLNB in low-risk breast cancer in patients ≥70 years: practice patterns and trends in a national cohort
Location: C101
Abstract Presenter: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
Submitter: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
Author: Gabriella N. Tortorello, MD – Hospital of the University of Pennsylvania
Author: Neha Shafique, MD – Hospital of the University of Pennsylvania
Author: Anushka Dheer – Hospital of the University of Pennsylvania
Author: Julia Tchou, MD PhD – University of Pennsylvania
Author: Oluwadamilola M. Fayanju, MD, MA, MPHS, FACS (she/her/hers) – University of Pennsylvania
Author: John Miura, MD – Hospital of the University of Pennsylvania
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
Breast
Saturday, Mar 23rd
9:10am – 9:20am ET
19: Trends in Patient-Reported Outcomes after Breast-Conserving Surgery and Partial Breast vs Whole Breast Irradiation
Location: C101
Abstract Presenter: Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Julia M. Chandler, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Minji Kim, BS – Memorial Sloan Kettering Cancer Center
Author: Varadan Sevilimedu, DrPH – Memorial Sloan Kettering Cancer Center
Author: Tiana V. Le, BS – Memorial Sloan Kettering Cancer Center
Author: Jonas A. Nelson, MD, MPH – Memorial Sloan Kettering Cancer Center
Author: Lior Z. Braunstein, MD – Memorial Sloan Kettering Cancer Center
Author: Monica Morrow, MD – Memorial Sloan Kettering Cancer Center
Author: Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center
Author: Audree B. Tadros, MD, MPH – Memorial Sloan Kettering Cancer Center
Breast
Saturday, Mar 23rd
10:00am – 10:30am ET
Breast Poster Presentations 2
Location: C110
Poster Session Moderator: Philip Spanheimer, MD (he/him/his) – University of North Carolina
Poster Session Moderator: Olga Kantor, MD (she/her/hers) – Brigham and Women's Hospital
Breastnon-CMEPosters
Saturday, Mar 23rd
10:00am – 10:06am ET
P5: In-Breast Tumor Progression During Neoadjuvant Chemotherapy- Impact on and Factors Influencing Distant Recurrence-Free Survival
Location: C110
Oral Poster Presenter: Kathryn M. Eckert, DO (she/her/hers) – Mayo Clinic
Submitter: Kathryn M. Eckert, DO (she/her/hers) – Mayo Clinic
Author: Kathryn M. Eckert, DO (she/her/hers) – Mayo Clinic
Author: Tanya L. Hoskin, MS – Mayo Clinic
Author: Matthew P. Goetz, MD – Mayo Clinic
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Breast
Saturday, Mar 23rd
10:06am – 10:12am ET
P6: Comparison of Survival Outcomes for Select Patients with Stage III vs Stage IV Disease
Location: C110
Oral Poster Presenter: Anna D. Louie, MD – Duke University Medical Center
Author: Anna D. Louie, MD – Duke University Medical Center
Author: Samantha M. Thomas, MS – Duke Cancer Institute
Author: Laura H. Rosenberger, MD MS (she/her/hers) – Duke University
Author: Gayle D. DiLalla, MD – Department of Surgery, Duke University Medical Center
Author: Kendra J. Parrish, D.O. – Duke University
Author: Ton Wang, MD, MS – Duke University
Author: Hannah E. Woriax, MD (she/her/hers) – Duke University Medical Center
Author: E. Shelley Hwang, MD, MPH – Duke University School of Medicine
Author: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Breast
Saturday, Mar 23rd
10:12am – 10:18am ET
P7: The clinical relevance of Mu-opioid receptor gene (OPRM1) expression in breast cancer
Location: C110
Oral Poster Presenter: Faisal S. Jehan, MD, FICS – Roswell Park Comprehensive Cancer Center.
Submitter: Faisal S. Jehan, MD, FICS – Roswell Park Comprehensive Cancer Center.
Author: Faisal S. Jehan, MD, FICS – Roswell Park Comprehensive Cancer Center.
Author: Masanori Oshi, MD – Roswell Park Comprehensive Cancer Center
Author: Itaru Endo, MD PhD – University of Yokohama
Author: Kazuaki Takabe, MD, PhD – Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center
Breast
Saturday, Mar 23rd
10:18am – 10:24am ET
P8: Reducing Tumor Recurrence and Adhesion Development with Deionized Water in Mouse Models
Location: C110
Author: Ashkan Zandi, PhD – School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA
Oral Poster Presenter: Fatemeh Shojaeian, MD, MPH – Johns Hopkins University School of Medicine
Submitter: Fatemeh Shojaeian, MD, MPH – Johns Hopkins University School of Medicine
Author: Cletus A. Arciero, M.D. – Emory University School of Medicine
Breast